BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37107601)

  • 1. Stable Isotope Tracing Reveals an Altered Fate of Glucose in
    Wise JTF; Yin X; Ma X; Zhang X; Hein DW
    Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of arylamine N-acetyltransferase 1 in MDA-MB-231 human breast cancer cells reduces primary and secondary tumor growth in vivo with no significant effects on metastasis.
    Doll MA; Ray AR; Salazar-González RA; Shah PP; Vega AA; Sears SM; Krueger AM; Hong KU; Beverly LJ; Hein DW
    Mol Carcinog; 2022 May; 61(5):481-493. PubMed ID: 35133049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of arylamine
    Hong KU; Gardner JQ; Doll MA; Stepp MW; Wilkey DW; Benz FW; Cai J; Merchant ML; Hein DW
    Toxicol Rep; 2022; 9():1566-1573. PubMed ID: 36158865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockout of human arylamine N-acetyltransferase 1 (NAT1) in MDA-MB-231 breast cancer cells leads to increased reserve capacity, maximum mitochondrial capacity, and glycolytic reserve capacity.
    Carlisle SM; Trainor PJ; Doll MA; Stepp MW; Klinge CM; Hein DW
    Mol Carcinog; 2018 Nov; 57(11):1458-1466. PubMed ID: 29964355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dataset for proteomic analysis of arylamine
    Hong KU; Gardner JQ; Doll MA; Stepp MW; Wilkey DW; Benz FW; Cai J; Merchant ML; Hein DW
    Data Brief; 2022 Dec; 45():108634. PubMed ID: 36426076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9 knockout of human arylamine N-acetyltransferase 1 in MDA-MB-231 breast cancer cells suggests a role in cellular metabolism.
    Carlisle SM; Trainor PJ; Hong KU; Doll MA; Hein DW
    Sci Rep; 2020 Jun; 10(1):9804. PubMed ID: 32555504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of cytidine deaminase in NAT1 knockout breast cancer cells.
    Hong KU; Tagnedji AH; Doll MA; Walls KM; Hein DW
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5047-5060. PubMed ID: 36329350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Arylamine
    Carlisle SM; Trainor PJ; Doll MA; Hein DW
    Front Pharmacol; 2021; 12():803254. PubMed ID: 35046826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and small molecule inhibition of arylamine N-acetyltransferase 1 reduces anchorage-independent growth in human breast cancer cell line MDA-MB-231.
    Stepp MW; Doll MA; Carlisle SM; States JC; Hein DW
    Mol Carcinog; 2018 Apr; 57(4):549-558. PubMed ID: 29315819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Untargeted polar metabolomics of transformed MDA-MB-231 breast cancer cells expressing varying levels of human arylamine
    Carlisle SM; Trainor PJ; Yin X; Doll MA; Stepp MW; States JC; Zhang X; Hein DW
    Metabolomics; 2016 Jul; 12(7):. PubMed ID: 27872580
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Stepp MW; Salazar-González RA; Hong KU; Doll MA; Hein DW
    J Oncol; 2019; 2019():3860426. PubMed ID: 31531019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arylamine N-acetyltransferase 1 deficiency inhibits drug-induced cell death in breast cancer cells: switch from cytochrome C-dependent apoptosis to necroptosis.
    McAleese CE; Butcher NJ; Minchin RF
    Breast Cancer Res Treat; 2022 Oct; 195(3):223-236. PubMed ID: 35918499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of human arylamine N-acetyltransferase I knockdown in triple-negative breast cancer cell lines.
    Tiang JM; Butcher NJ; Minchin RF
    Cancer Med; 2015 Apr; 4(4):565-74. PubMed ID: 25627111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arylamine
    Li P; Butcher NJ; Minchin RF
    Mol Pharmacol; 2019 Nov; 96(5):573-579. PubMed ID: 31444237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arylamine N-acetyltransferase 1 protects against reactive oxygen species during glucose starvation: Role in the regulation of p53 stability.
    Wang L; Minchin RF; Butcher NJ
    PLoS One; 2018; 13(3):e0193560. PubMed ID: 29518119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo metabolic flux profiling with stable isotopes discriminates sites and quantifies effects of mitochondrial dysfunction in C. elegans.
    Vergano SS; Rao M; McCormack S; Ostrovsky J; Clarke C; Preston J; Bennett MJ; Yudkoff M; Xiao R; Falk MJ
    Mol Genet Metab; 2014 Mar; 111(3):331-341. PubMed ID: 24445252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect arylamine N-acetyltransferase 1 on morphology, adhesion, migration, and invasion of MDA-MB-231 cells: role of matrix metalloproteinases and integrin αV.
    Li P; Butcher NJ; Minchin RF
    Cell Adh Migr; 2020 Dec; 14(1):1-11. PubMed ID: 31910058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiolipin-induced activation of pyruvate dehydrogenase links mitochondrial lipid biosynthesis to TCA cycle function.
    Li Y; Lou W; Raja V; Denis S; Yu W; Schmidtke MW; Reynolds CA; Schlame M; Houtkooper RH; Greenberg ML
    J Biol Chem; 2019 Jul; 294(30):11568-11578. PubMed ID: 31186346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Untargeted stable isotope-resolved metabolomics to assess the effect of PI3Kβ inhibition on metabolic pathway activities in a PTEN null breast cancer cell line.
    Lackner M; Neef SK; Winter S; Beer-Hammer S; Nürnberg B; Schwab M; Hofmann U; Haag M
    Front Mol Biosci; 2022; 9():1004602. PubMed ID: 36310598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the metabolic phenotype of breast cancer cells by multiple tracer stable isotope resolved metabolomics.
    Lane AN; Tan J; Wang Y; Yan J; Higashi RM; Fan TW
    Metab Eng; 2017 Sep; 43(Pt B):125-136. PubMed ID: 28163219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.